Procter & Gamble to Acquire Thorne for $3.8 Billion in Strategic Health Expansion Procter & Gamble (P&G) has announced its intention to acquire Thorne, a leading supplement brand, for $3.8 billion, marking a significant step in the company’s strategy to expand its health and wellness division. The deal, set to be formally announced on Tuesday, was highlighted by P&G CEO Shailesh Jejurikar during an interview on CNBC’s “Squawk on the Street.” Jejurikar emphasized that the acquisition is a deliberate move to strengthen P&G’s position in the growing health and wellness market, which has seen increasing consumer demand for premium, science-backed products. Thorne, a well-established brand in the dietary supplement industry, has been a key player in the health sector for decades. Founded in 1984, the company went public in late 2021 at a valuation of $525 million. In 2023, it was acquired by private equity firm L Catterton in a $680 million deal, which positioned Thorne for rapid growth. By 2025, the company had achieved annual revenue exceeding $500 million, a testament to its strong market presence and consumer appeal. The acquisition is part of a broader trend among consumer goods giants seeking to capitalize on the rising popularity of health-focused products. Earlier this year, Unilever made a similar move by acquiring Grüns, a gummy supplement brand, underscoring the industry’s shift toward premium, direct-to-consumer offerings. For P&G, the deal represents an opportunity to diversify its portfolio and tap into a segment that has shown resilience despite macroeconomic challenges. Jeurikar described Thorne as a “well-run operation” with a long-standing reputation for quality and innovation.#procter_gamble #thorne #shailesh_jeurikar #lcatterton #colin_watts
